JanOne Inc. (JAN)
- Previous Close
4.5150 - Open
4.5900 - Bid 4.6900 x 100
- Ask 4.8300 x 100
- Day's Range
4.2500 - 4.8300 - 52 Week Range
0.2200 - 5.0800 - Volume
186,521 - Avg. Volume
317,796 - Market Cap (intraday)
41.078M - Beta (5Y Monthly) 2.18
- PE Ratio (TTM)
-- - EPS (TTM)
-4.2700 - Earnings Date May 22, 2024 - May 29, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. Its lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.
www.janone.comRecent News: JAN
Performance Overview: JAN
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: JAN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: JAN
Valuation Measures
Market Cap
41.08M
Enterprise Value
41.78M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
0.65
Enterprise Value/EBITDA
-12.68
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-9.09%
Return on Equity (ttm)
-122.02%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-17.09M
Diluted EPS (ttm)
-4.2700
Balance Sheet and Cash Flow
Total Cash (mrq)
5k
Total Debt/Equity (mrq)
6.31%
Levered Free Cash Flow (ttm)
-10.49M